LI, HUI-YIN,RODGERS, JAMES D.,LI, Hui-Yin,RODGERS, James D.
申请号：
RSP20140152
公开号：
RS53245B
申请日:
2008.06.12
申请国别(地区):
RS
年份:
2014
代理人:
摘要：
The present invention provides salt forms of (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1 H-pyrazol-1-yl)-3-cyclopentylpropanenitrile that are useful in the modulation of Janus kinase activity and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases.So izabrana iz grupe koju čine:(R)-3-(4-(7H-pirolo[2,3-d]pirimidin-4-il)-1 H-pirazol-1-il)-3-ciklopentilpropan-nitrilna so maleinske kiseline； (R)-3-(4-(7H-pirolo[2,3-d]pirimidin-4-il)-1H-pirazol-1-il)-3-ciklopentilpropan-nitrilna so sumpome kiseline； i (R)-3-(4-(7H-pirolo[2,3-d]pirimidin-4-il)-1 H-pirazol-1-il)-3-ciklopentilpropan-nitrilna so fosforne kiseline.Prijava sadrži još 18 patentnih zahteva.
